Index of artpub/2019/pmc_31749092/

Armstrong, April
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis : Results from Greater Than 17,000 Patient-Years of Exposure
2019
https://ddd.uab.cat/record/227862